MEDIFAST INC (MED) News

MEDIFAST INC (MED): $31.32

0.62 (-1.94%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

A

Add MED to Watchlist
Sign Up

Industry: Medical - Consumer Goods

Industry

A

Ranked

#7 of 9

in industry

Filter MED News Items

MED News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MED News Highlights

  • MED's 30 day story count now stands at 13.
  • Over the past 20 days, the trend for MED's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
  • LFMD, GLP and DEC are the most mentioned tickers in articles about MED.

Latest MED News From Around the Web

Below are the latest news stories about MEDIFAST INC that investors may wish to consider to help them evaluate MED as an investment opportunity.

Medifast's (MED) Holistic Health Solution, Innovation Bode Well

Medifast's (MED) focus on combining lifestyle coaching with innovative health solutions and targeting diverse markets bode well amid challenges in customer acquisition and high costs.

Yahoo | December 26, 2023

Is Medifast, Inc. (NYSE:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Key Insights Using the 2 Stage Free Cash Flow to Equity, Medifast fair value estimate is US$54.94 Medifast is estimated...

Yahoo | December 25, 2023

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

Avoid these seven dividend stocks to sell at all costs, as their payouts may not be a sustainable as they seem.

Thomas Niel on InvestorPlace | December 18, 2023

Potential 300% Upside: Uncovering Medifast's Investment Opportunity

A look at the company's innovative wellness, robust growth and investment upside

Yahoo | December 15, 2023

Medifast (MED) Collaborates With LifeMD, Discontinues Dividend

Medifast (MED) penetrates the medically supported weight loss market via a collaboration with LifeMD, Inc. (LFMD). The company discontinues quarterly cash dividends.

Yahoo | December 14, 2023

S&P 500, Nasdaq Higher After Upbeat PPI Reading

Wall Street is holding its breath ahead of this afternoon's interest rate decision from the Federal Reserve.

TalkMarkets.com | December 13, 2023

Once an Ozempic Skeptic, This Diet-Company Giant Has Changed Its Mind

Investment in telehealth provider LifeMD would give Medifast customers access to doctors who can prescribe the medications.

Yahoo | December 13, 2023

Once Powell Is Out of the Way, I'm Getting Back to Small Caps

After today's meeting, we should have some better opportunities for positioning. Also, let's take another look at this small health care stock.

Yahoo | December 13, 2023

LifeMD Stock Pops on Medifast Agreement. It’s All About Weight-Loss Drugs.

Shares of LifeMD were rising sharply Wednesday after the provider of virtual primary care services said it was teaming up with Medifast —a health and wellness company known for its lifestyle service Optavia—to present a ”transformative weight management solution.” Under the agreement, Medifast will use LifeMD virtual care technology platform to provide Optavia clients access to a weight management program that includes GLP-1 medications, drugs that mimic natural hormones that impact the body’s feelings of fullness.

Yahoo | December 13, 2023

Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, a Virtual Primary Care Provider, and Adjusting its Capital Allocation Policy

BALTIMORE, December 13, 2023--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today launched the first phase of its business transformation, as part of its commitment to providing comprehensive health and wellness solutions to customers across the United States. The company will expand into the medically supported weight loss market through a collaboration with LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual

Yahoo | December 13, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!